Article info
PDFTherapuetics
Review: pioglitazone does not reduce risk of mortality or cardiovascular events in type 2 diabetes
Citation
Review: pioglitazone does not reduce risk of mortality or cardiovascular events in type 2 diabetes
Publication history
- First published March 30, 2007.
Online issue publication
October 25, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2007 by the ACP-ASIM and BMJ Publishing Group for Evidence-Based Medicine and by the ACP-ASIM for portions reproduced from ACP Journal Club